Dare Bioscience
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DARE and other ETFs, options, and stocks.About DARE
Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil.
CEOSabrina Martucci Johnson
CEOSabrina Martucci Johnson
Employees23
Employees23
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2005
Founded2005
Employees23
Employees23
DARE Key Statistics
Market cap27.77M
Market cap27.77M
Price-Earnings ratio-4.37
Price-Earnings ratio-4.37
Dividend yield—
Dividend yield—
Average volume83.38K
Average volume83.38K
High today$2.00
High today$2.00
Low today$1.93
Low today$1.93
Open price$1.99
Open price$1.99
Volume13.79K
Volume13.79K
52 Week high$9.19
52 Week high$9.19
52 Week low$1.61
52 Week low$1.61
Stock Snapshot
With a market cap of 27.77M, Dare Bioscience(DARE) trades at $1.94. The stock has a price-to-earnings ratio of -4.37.
As of 2026-01-14, Dare Bioscience(DARE) stock has fluctuated between $1.93 and $2.00. The current price stands at $1.94, placing the stock +0.7% above today's low and -2.6% off the high.
The Dare Bioscience(DARE)'s current trading volume is 13.79K, compared to an average daily volume of 83.38K.
In the last year, Dare Bioscience(DARE) shares hit a 52-week high of $9.19 and a 52-week low of $1.61.
In the last year, Dare Bioscience(DARE) shares hit a 52-week high of $9.19 and a 52-week low of $1.61.
People also own
Based on the portfolios of people who own DARE. This list is generated using Robinhood data, and it’s not a recommendation.